{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:35:53Z","timestamp":1778394953701,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.diagmicrobio.2024.116181","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T22:14:29Z","timestamp":1704492869000},"page":"116181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intermethod comparability analyses of gepotidacin antimicrobial susceptibility tests using a large collection of globally collected Escherichia coli and Staphylococcus saprophyticus clinical isolates"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5961-6238","authenticated-orcid":false,"given":"S.J. Ryan","family":"Arends","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Scangarella-Oman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116181_bib0001","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/pathogens12040623","article-title":"Urinary tract infections: the current scenario and future prospects","volume":"12","author":"Mancuso","year":"2023","journal-title":"Pathogens"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116181_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0003","unstructured":"Akbar, R., Ten threats to global health in 2019. 2019 September 13, 2019; Available from: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0004","unstructured":"CDC. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019. Available from: https:\/\/www.cdc.gov\/drugresistance\/biggest-threats."},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116181_bib0005","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0006","unstructured":"ClincalTrials.gov, A study to evaluate efficacy and safety of gepotidacin in the treatment of uncomplicated urinary tract infection (UTI) - NCT04020341. 2021; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04020341."},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0007","unstructured":"ClincalTrials.gov, A study evaluating efficacy and safety of geptidacin compared with ceftriaxone plus azithromycin in the treatment of uncomplicated urogenital gonorrhea - NCT04010539. 2021; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04010539."},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0008","unstructured":"ClinicalTrials.gov, Comparative study to evaluate efficacy and safety of gepotidacin to nitrofurantoin in treatment of uncomplicated urinary tract infection (UTI). Clinical Trials Identifier NCT04187144. 2022 January 2022]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04187144."},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116181_bib0009","doi-asserted-by":"crossref","first-page":"e02047","DOI":"10.1128\/AAC.02047-16","article-title":"In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae","volume":"61","author":"Farrell","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116181_bib0010","doi-asserted-by":"crossref","first-page":"e00468","DOI":"10.1128\/AAC.00468-17","article-title":"Gepotidacin (GSK2140944) in vitro activity against Gram-positive and Gram-negative bacteria","volume":"61","author":"Flamm","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2024.116181_bib0011","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/jac\/dky162","article-title":"In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae","volume":"73","author":"Jacobsson","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116181_bib0012","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/AAC.02820-15","article-title":"In vitro activity of gepotidacin, a novel triazaacenaphthylene bacterial topoisomerase inhibitor, against a broad spectrum of bacterial pathogens","volume":"60","author":"Biedenbach","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"7309","key":"10.1016\/j.diagmicrobio.2024.116181_bib0013","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2024.116181_bib0014","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acsinfecdis.8b00315","article-title":"Mechanistic and structural basis for the actions of the antibacterial gepotidacin against Staphylococcus aureus gyrase","volume":"5","author":"Gibson","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0015","series-title":"Performance standards for antimicrobial susceptibility testing: 32nd informational supplement","article-title":"M100Ed33","author":"CLSI","year":"2023"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116181_bib0016","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JCM.00656-14","article-title":"Determination of disk diffusion and MIC quality control guidelines for GSK2140944, a novel bacterial type II topoisomerase inhibitor antimicrobial agent","volume":"52","author":"Ross","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116181_bib0017","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1128\/AAC.00527-16","article-title":"Multicenter investigation of gepotidacin (GSK2140944) agar dilution quality control determinations for Neisseria gonorrhoeae ATCC 49226","volume":"60","author":"Jones","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0018","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","article-title":"M07Ed11","author":"CLSI","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0019","series-title":"Performance standards for antimicrobal disk susceptibility tests","article-title":"M02Ed13","author":"CLSI","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2024.116181_bib0020","series-title":"Antimicrobial susceptibility test (AST) systems\u2014class II special controls guidance for industry and FDA","author":"FDA","year":"2018"},{"issue":"7","key":"10.1016\/j.diagmicrobio.2024.116181_bib0021","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.00093-09","article-title":"Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116181_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0041-1731137","article-title":"Detection of colistin resistance in carbapenem resistant Enterobacteriaceae by reference broth microdilution and comparative evaluation of three other methods","volume":"13","author":"Kar","year":"2021","journal-title":"J Lab Physicians"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2024.116181_bib0023","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/JCM.00001-14","article-title":"Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method","volume":"52","author":"Marchaim","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2024.116181_bib0024","doi-asserted-by":"crossref","first-page":"e00695","DOI":"10.1128\/JCM.00695-20","article-title":"Imipenem-relebactam susceptibility testing of Gram-negative bacilli by agar dilution, disk diffusion, and gradient strip methods compared with broth microdilution","volume":"58","author":"Hakvoort","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2024.116181_bib0025","doi-asserted-by":"crossref","first-page":"e01797","DOI":"10.1128\/JCM.01797-18","article-title":"Evaluation of ciprofloxacin and levofloxacin disk diffusion and Etest using the 2019 enterobacteriaceae CLSI breakpoints","volume":"57","author":"Humphries","year":"2019","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889324000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:00:38Z","timestamp":1760004038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889324000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0732889324000105"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116181","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermethod comparability analyses of gepotidacin antimicrobial susceptibility tests using a large collection of globally collected Escherichia coli and Staphylococcus saprophyticus clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116181"}}